Objectives: To determine aneuploidy for chromosome 16 by recycling nuc
lei of cells already analyzed for chromosomes X, Y, 18, 13, and 21 usi
ng multiple-probe fluorescence in situ hybridization in preimplantatio
n human embryos in a time frame compatible with clinical NF and to ass
ess the incidence of chromosome 16 aneuploidy in embryos related to ma
ternal age, Design: Prospective experimental study. Setting: In vitro
fertilization program in a tertiary center. Patients: One hundred four
consenting patients undergoing IVF. Main Outcome Measures: Chromosome
16 ploidy was analyzed in a total of 195 embryos. In 89 embryos, a st
andard multiple-probe fluorescence in situ hybridization was used for
chromosomes X, Y, 18, and 16 (series 1). The remaining 106 embryos (se
ries 2) were reanalyzed with a new procedure for chromosome 16, which
involves rehybridization with a digoxigenin-labeled cr satellite probe
after the standard analysis for chromosomes X, Y, 18, 13, and 21 was
completed. The embryos were assigned to one of three groups according
to the women's age; group 1: less than or equal to 34 years (n = 34),
group 2: 35 to 39 years (n = 47); group 3: greater than or equal to 40
years (n = 23). Results: Successful analysis, including biopsy, fixat
ion, and fluorescence in situ hybridization was achieved in 86% of the
blastomeres within approximately 10 hours. a significant relationship
was found between the rate of aneuploidy for chromosome 16 and increa
sing maternal age: group 1: 0%, group 2: 6.3%, and group 3: 11.7%. Mon
osomy for chromosome 16 was found in 72.7% of the II embryos carrying
chromosome 16 anomalies, with the remaining three embryos having two t
risomies and one tetrasomy. This new protocol was applied clinically t
o five patients undergoing reimplantation aneuploidy assessment. Aneup
loidy for chromosome 16 was found in five embryos from three of those
patients. Conclusions: This study demonstrates that preimplantation ge
netic diagnosis of the major human aneuploidies is achievable within a
time frame compatible with IVF. In addition, this study confirms, for
embryos, the existing data from spontaneous abortions suggesting that
chromosome 16 aneuploidy increases with maternal age. The high preval
ence of embryonic monosomy, which is rarely found in spontaneous abort
ions, suggests that monosomy 16 could be a factor-associated with fail
ure of implantation, as well as pointing to a different mechanism invo
lved in the generation of chromosome 16 aneuploidy.